Daiwa Securities Group’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
Other funds holding CRL
Daiwa Securities Group's CRL Position: Q3 2026 in Review
Daiwa Securities Group reduced its Charles River Laboratories (CRL) stake by 27% in Q3 2026, selling an estimated $857K and leaving 8,961 shares worth $2.64M. The position accounts for ﹤0.01% of the portfolio, ranked #643.
Daiwa Securities Group first reported a position in CRL in Q2 2021 and has held it in 22 quarters since. The position peaked at $2.77M in Q2 2026. 642 funds tracked by Wall St. Rank hold CRL as of Q3 2026.
- Daiwa Securities Group held 8,961 shares of Charles River Laboratories worth $2.64M as of Q3 2026.
- Daiwa Securities Group sold 3,253 Charles River Laboratories shares in Q3 2026, an estimated $857K.
- Charles River Laboratories made up ﹤0.01% of Daiwa Securities Group's portfolio in Q3 2026, its #643 holding.
- Daiwa Securities Group first reported a position in Charles River Laboratories in Q2 2021 and has held it in 22 quarters since.
- Daiwa Securities Group's Charles River Laboratories position peaked at $2.77M in Q2 2026.
- 642 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2026.
Based on Daiwa Securities Group's 13F filing for Q3 2026, filed 29 Oct 2026.